The goal of this prospective implementation study is to understand the impact of a blood-based screening test (BBST) for colorectal cancer (CRC) on patient acceptability of and adherence to CRC screening as well as the rate of follow-up BBST in those with negative BBST at a 1-year interval.

Additional aims include assessing the impact of digital patient navigation intervention on the rate of follow-up colonoscopy in individuals with positive BBST. Patients will be randomized into the non-intervention arm or the intervention with an app arm.

Inclusion Criteria:

• patients aged 45-84 years of age
• Considered by health-care providers to be "average risk" for CRC as determined by USPSTF guidelines
• If a patient opts for BBST, they are able and willing to provide blood samples per protocol
• Ability to understand and the willingness to participate in the study
• Must have been seen in HTPN clinic within the past 24 months from study activation
• Must have active MyBSW app portal account and/or establish account during study recruitment

Exclusion Criteria:

• Patients with a personal history of CRC
• Patients with a known high-risk family history of CRC precluding the patient from being average risk
• Patients with known diagnosis of inflammatory bowel disease or history of polyps
• Patients who are currently symptomatic for CRC such as: blood in the stool
• Patients with any known medical condition which, in the opinion of the investigator, should preclude enrollment into the study
• Have a recorded up to date CRC screening in the EMR (within 1 year for FIT, 3 years for mt-sDNA, 10 years for colonoscopy)
• Patients with a previous abnormal colonoscopy finding who are due for surveillance.